lipoteichoic acid

**Structure and location** - LTA is a polymer of glycerol-phosphate (or ribitol-phosphate) repeats. A glycolipid anchor attaches it to the cytoplasmic (plasma) membrane, and the polymer extends outward through the thick peptidoglycan layer. - It is found only in gram-positive bacteria. Gram-negative bacteria have lipopolysaccharide (LPS, endotoxin) in the outer membrane instead. - Wall teichoic acid (WTA) is a related polymer. It is covalently linked to peptidoglycan (not the membrane) and also extends outward. - Both LTA and WTA carry D-alanine esters, which contribute to the negative charge of the cell envelope and to resistance to cationic antimicrobial peptides.

**Functions** - Maintains cell wall integrity and cell envelope charge. It also helps regulate autolytic enzymes. - Mediates adherence and biofilm formation. For example, *S. pyogenes* LTA helps attach to pharyngeal epithelial cells through fibronectin binding (with M protein). *S. aureus* LTA contributes to adherence to host cells and biomaterials. - It is a virulence factor and a pathogen-associated molecular pattern (PAMP).

**Pathophysiology (high-yield)** - LTA is recognized by TLR2, usually as a TLR2/TLR6 heterodimer, on macrophages and monocytes. This activates NF-κB and releases IL-1, IL-6, and TNF-α. - This can cause fever, hypotension, and in severe cases septic shock from gram-positive organisms. Peptidoglycan fragments and superantigens also contribute. - By contrast, LPS (lipid A) in gram-negative bacteria signals through TLR4 with CD14 and MD-2. - Remember: gram-positive PAMPs (LTA, peptidoglycan) → TLR2. Gram-negative LPS → TLR4. Flagellin → TLR5. Unmethylated CpG DNA → TLR9.

**Clinical associations** - *S. aureus*: skin infections, endocarditis, osteomyelitis, toxic shock syndrome (TSST-1 is a superantigen, separate from LTA). - *S. pyogenes* (group A strep): pharyngitis, impetigo, rheumatic fever. LTA is part of its adherence mechanism. - *S. pneumoniae*: its LTA has a phosphocholine-containing form (Forssman antigen). Phosphocholine binds the platelet-activating factor receptor and helps adherence in the respiratory tract. - Enterococcus: it has a group D antigen, which is an LTA. This is a high-yield association for the Lancefield classification of group D streptococci (*S. bovis/gallolyticus*, enterococci). - Lancefield classification: Group A and B strep are classified by the C-carbohydrate in the cell wall. Group D is classified by LTA. - Anti-LTA antibody and LTA-targeted therapies have been studied in neonatal sepsis, but they have not shown clinical benefit.

**Comparison with gram-negative cell wall** - Gram-positive: thick peptidoglycan, teichoic acids (LTA and WTA), no outer membrane, no periplasmic space (minimal). - Gram-negative: thin peptidoglycan, outer membrane with LPS, periplasmic space, and porins.

**Pharmacology tie-in** - Beta-lactams and vancomycin inhibit peptidoglycan synthesis. Daptomycin disrupts the membrane of gram-positive bacteria. LTA synthesis itself is not a standard antibiotic target.

**Exam pearls** - Teichoic acids are gram-positive only. - LTA is membrane-anchored and WTA is peptidoglycan-anchored. - LTA → TLR2. LPS → TLR4. - Group D antigen is an LTA.